Presidio Medical raises $72M for ultra-low frequency neuromo

Presidio Medical closed a $72 million Series C funding round to support its ultra-low frequency (ULF) neuromodulation platform.

Related Keywords

David Neustaedter , Michael Onuscheck , , Presidio Medical , Invus Opportunities , Action Potential Venture , Shangbay Capital , San Francisco Based Presidio ,